Nov 14, 2024 · Benefits beyond weight loss. Along with helping to control blood sugar and boosting weight loss, GLP-1 agonists and SGLT-2 inhibitors seem to have other health benefits. Research has found that some of these medicines may lower the risk of certain serious health conditions, such as kidney disease, heart disease, heart failure and stroke.

Greater GE delays at three months were associated with greater weight loss at three, six and 12 months. The percentage total body weight loss was significantly greater in the ESG group than in the LS interventions group at three, six and 12 months. GM was preserved, and fasting ghrelin, GLP-1 and PYY significantly increased 18 months after ESG.

Dec 12, 2023 · Glucagon-like peptide 1 (GLP-1) receptor agonists. These agents can lead to significant weight loss. According to Dr. Watt, developing a solid understanding of how the various GLP-1 receptor agonists differ from one another may help clinicians choose the most appropriate agent for an individual patient. The Hepatology article contains a ...

Hu M, et al. Effect of hemoglobin A1c reduction or weight reduction on blood pressure in glucagon-like peptide-1receptor agonist and sodium-glucose cotransporter-2 inhibitor treatment in type 2 diabetes mellitus: A meta-analysis.

Aug 17, 2021 · Medical therapy for weight loss — including dietary adjustments, exercise and pharmacotherapy — is typically recommended for patients with a body mass index (BMI) of 30 to 40. Surgical and endoscopic bariatric procedures are typically considered for patients with a BMI greater than 40, or for patients with metabolic comorbidities and a BMI ...

May 8, 2024 · And burning more calories than you take in leads to weight loss. To lose weight, most people need to cut the number of calories they eat and move more. This is according to the 2020-2025 Dietary Guidelines for Americans. Most often, that means cutting daily calories by 500 to 750 to lose 1 1/2 pounds (0.7 kilograms) a week.

Oct 29, 2022 · Phentermine by itself (Adipex-P, Lomaira) also is used for weight loss. It's one of four similar weight-loss drugs approved for use for less than 12 weeks, called short-term use. The other drugs in this group aren't often prescribed. Semaglutide. Semaglutide also is used to help control type 2 diabetes. You take it as a weekly shot to manage ...

Oct 1, 2024 · Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight and keep the weight off in patients with at least one weight-related medical condition. This medicine is available only with your doctor's prescription.

Apr 1, 2024 · It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is also used to help lose weight and keep the weight off in patients with obesity caused by certain conditions.

Jun 16, 2023 · A dual incretin agonist (GLP-1/glucose-dependent insulinotropic peptide) tirzepatide also is efficacious in treating obesity, improving glycemic control and reducing liver fat content. Researchers have demonstrated the ability of other dual incretin agonists, such as cotadutide and pemvidutide, to reduce significant hepatic fibrosis in both ...